CD19 and congenital rubella syndrome: First, investigators tried to identify clinical factors promoting CAR T-cell expansion, since high CAR T-cell peak counts in patients with CD19-positive lymphoid malignancies have been consistently correlated with the development of severe CRS (16, 40, 72, 73) and NTX (22, 73).